1
Inpharma 1476 - 26 Feb 2005 Guidelines for treating opportunistic infections among paediatric individuals infected with, or exposed to, HIV infections have been released. The guidelines were developed by a paediatric working group of the US Centers for Disease Control and Prevention, the National Institutes of Health and the Infectious Diseases Society of America, and serve as a companion to previously released guidelines for adult patients. * The paediatric recommendations point out that the natural history of opportunistic infections among paediatric patients might differ from that observed among adults, and that laboratory diagnosis may prove more difficult. Treatment recommendations should consider differences between adult and paediatric patients with regards to drug dosing, pharmacokinetics, formulations, administration and toxicities, state the guidelines. * see Inpharma 1345: 4, 6 Jul 2002; 800912107 Mofenson LM, et al. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clinical Infectious Diseases 40 (Suppl. 1): 1-84, 1 Feb 2005 800967722 1 Inpharma 26 Feb 2005 No. 1476 1173-8324/10/1476-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Guidelines for treating paediatric opportunistic infections released

  • View
    215

  • Download
    1

Embed Size (px)

Citation preview

Inpharma 1476 - 26 Feb 2005

■ Guidelines for treating opportunistic infectionsamong paediatric individuals infected with, or exposedto, HIV infections have been released. The guidelineswere developed by a paediatric working group of theUS Centers for Disease Control and Prevention, theNational Institutes of Health and the InfectiousDiseases Society of America, and serve as acompanion to previously released guidelines for adultpatients.* The paediatric recommendations point outthat the natural history of opportunistic infectionsamong paediatric patients might differ from thatobserved among adults, and that laboratory diagnosismay prove more difficult. Treatment recommendationsshould consider differences between adult andpaediatric patients with regards to drug dosing,pharmacokinetics, formulations, administration andtoxicities, state the guidelines.* see Inpharma 1345: 4, 6 Jul 2002; 800912107

Mofenson LM, et al. Treating opportunistic infections among HIV-exposedand infected children: recommendations from CDC, the National Institutes ofHealth, and the Infectious Diseases Society of America. Clinical InfectiousDiseases 40 (Suppl. 1): 1-84, 1 Feb 2005 800967722

1

Inpharma 26 Feb 2005 No. 14761173-8324/10/1476-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved